Novartis has announced its plan to separate its generics and biosimilars division, Sandoz, into a new publicly traded standalone company. …
Latest Video
New Stories
-
The 'Week in Review' Podcast - 14 February
February 14, 2025 - - Podcast -
Merck team gathers in Sydney aiming to spark discovery and elevate humanity
February 14, 2025 - - Latest News -
The institution defends itself by effectively arguing that deaths are a necessary consequence
February 14, 2025 - - Latest News -
Research grants on patient-informed decision-making, but patients need not apply
February 14, 2025 - - Latest News -
Australian whooping cough cases still rising after record year
February 13, 2025 - - Latest News -
UK private health insurer to cover weight loss therapies
February 12, 2025 - - Latest News -
Immunoglobulin sales drives a strong first half for CSL but lower immunisation rates hit Seqirus
February 12, 2025 - - Latest News